The MOGE(S) classification of cardiomyopathy for clinicians.
about
Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse modelsCardiac Resynchronization Therapy in Non-Ischemic CardiomyopathyCofilin-2 phosphorylation and sequestration in myocardial aggregates: novel pathogenetic mechanisms for idiopathic dilated cardiomyopathy.Cardiac MRI evaluation of myocardial disease.Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.Summary of the 2015 International Paediatric Heart Failure Summit of Johns Hopkins All Children's Heart Institute.Nomenclature and systems of classification for cardiomyopathy in children.The MOGE(S) classification for cardiomyopathies: current status and future outlook.Recent Advances in Understanding and Managing Cardiomyopathy.Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy.Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients.Extending survival by reducing sudden death with implantable cardioverter-defibrillators: a challenging clinical issue in non-ischaemic and ischaemic cardiomyopathies.Genetic determinants of heart failure: facts and numbers.Clinical findings and prognosis of patients hospitalized for acute decompensated heart failure: Analysis of the influence of Chagas etiology and ventricular function.Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature
P2860
Q28066019-FDA8E679-B3C8-4E03-B837-F34AE503B6E4Q28075924-4A38AF7B-70CC-4C6D-9CC4-C734670892B9Q35232486-88C6576D-E140-4B94-89F4-4392F662FAEAQ38413105-8B25C93F-766C-406B-B09A-023B36238942Q38418005-34F5ABF1-0218-4CC3-A81C-4E2FFA1CE4B9Q38588150-1F6B1318-62A4-4CE7-91C4-611A62C962E4Q38588152-736215F8-DB66-409B-8E75-0A0F1D23BDDBQ38655527-36A4309A-08BD-43FF-BCA3-F6CF59B6C545Q41528372-C731A8FE-D508-4E79-803E-8688CEBC1FC3Q45069359-1AB9A257-3860-47C4-A131-9D91B0595A3CQ46403030-BA666543-6817-451C-B238-F57B6977DB03Q49819919-1B594225-D749-466B-AE8A-8E881B46573DQ49850125-1DBD7F6F-9342-4ABA-957B-22A478A1B56DQ50062333-91B52ABB-845B-4F68-94F1-DE4A1AC3569BQ58561653-B338C828-C3CB-4706-A4EA-84065AED3731
P2860
The MOGE(S) classification of cardiomyopathy for clinicians.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The MOGE(S) classification of cardiomyopathy for clinicians.
@en
type
label
The MOGE(S) classification of cardiomyopathy for clinicians.
@en
prefLabel
The MOGE(S) classification of cardiomyopathy for clinicians.
@en
P2093
P50
P1476
The MOGE(S) classification of cardiomyopathy for clinicians.
@en
P2093
Alessandra Serio
Jamil A Tajik
Maurizia Grasso
Navneet Narula
Riccardo Bellazzi
Robert O Bonow
P304
P356
10.1016/J.JACC.2014.05.027
P407
P577
2014-07-01T00:00:00Z